DCOY Decoy Therapeutics Inc.
Price Chart
Executive Summary
Decoy Therapeutics Inc. (DCOY) announced a 1-for-12 reverse stock split effective March 6, 2026, reducing outstanding shares from approximately 6.38 million to 532,000. The move is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing.
Actionable Insight
Monitor DCOY's stock price post-split to ensure it maintains above $1.00 to achieve Nasdaq compliance; watch for potential liquidity challenges due to reduced share count and higher per-share price
Key Facts
- Decoy Therapeutics is implementing a 1-for-12 reverse stock split effective March 6, 2026
- Outstanding shares will decrease from ~6.38 million to ~532,000
- The reverse split is designed to regain compliance with Nasdaq's $1.00 minimum bid price listing requirement
- The stock will begin trading on a split-adjusted basis on March 9, 2026 under the same ticker DCOY
- Authorized shares remain at 100 million; par value unchanged at $0.0001 per share
Financial Impact
No change to market capitalization or financial fundamentals; share count reduced from 6.38M to 532K with proportional price increase
Risk Factors
- Failure to sustain post-split price above $1.00 could lead to delisting
- Reduced liquidity from lower share count may deter some investors
- Reverse split may be perceived negatively by market as a sign of financial distress
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-092748 |
| Document: dcoy-ex99_1.htm | 0001193125-26-092748 |
| Document: dcoy-ex3_1.htm | 0001193125-26-092748 |
| Document: 0001193125-26-092748-index-headers.html | 0001193125-26-092748 |
| Document: 0001193125-26-092748-index.html | 0001193125-26-092748 |
| Document: 0001193125-26-092748.txt | 0001193125-26-092748 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
9d ago
|
DEFA14A
| $6.71 $6.61 | ▼ −1.49% | ▲ +1.11% | $6.01 (−10.43%) |
|
Apr 30, 2026
6w ago
|
10-K/A
| $6.05 $5.90 | ▼ −2.48% | ▼ −2.70% | $6.01 (−0.66%) |
|
Apr 2, 2026
10w ago
|
8-K
| $5.80 $5.89 | ▲ +1.55% | ▲ +1.08% | $6.01 (+3.62%) |
|
Mar 5, 2026
14w ago
|
8-K
| $7.00 $7.58 | ▲ +8.40% | ▲ +9.72% | $6.01 (−14.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access